Vir Biotechnology to Participate in the Jefferies 2026 London Healthcare Conference
Business Wire•02/11/2026•16:05 ET
0
Key Highlights
- ➤Vir Biotechnology (VIR) CEO Marianne De Backer will present at Jefferies 2026 London Healthcare Conference.
- ➤Presentation scheduled for November 18 at 10:30 a.m. GMT / 5:30 a.m. ET.
- ➤Vir Biotechnology’s clinical-stage portfolio includes chronic hepatitis delta and PRO-XTEN dual-masked T-cell engagers.
- ➤Vir Biotechnology holds exclusive oncology and infectious-disease rights to the PRO-XTEN masking platform.
Vir Biotechnology to Participate in the Jefferies 2026 London Healthcare Conference
Vir Biotechnology, Inc. (Nasdaq: VIR), today announced that Marianne De Backer, M.Sc., Ph.D., MBA, President and Chief Executive Officer, will present at the Jefferies 2026 London Healthcare Conference on Wednesday, November 18 at 10:30 a.m. GMT / 5:30 a.m. ET in London, United Kingdom.
Get started
Create a free account to read the full story.